Abcam PLC Financials

ABCMDelisted Stock  USD 23.59  0.56  2.32%   
Based on the measurements of operating efficiency obtained from Abcam PLC's historical financial statements, Abcam PLC is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.
  
Understanding current and past Abcam PLC Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Abcam PLC's financial statements are interrelated, with each one affecting the others. For example, an increase in Abcam PLC's assets may result in an increase in income on the income statement.

Abcam PLC Stock Summary

Abcam PLC competes with Anebulo Pharmaceuticals, Adagene, Acrivon Therapeutics,, AnaptysBio, and Mineralys Therapeutics,. Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. Abcam Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1682 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS0003802040
Business AddressDiscovery Drive, Cambridge,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.abcam.com
Phone44 12 2369 6000
CurrencyUSD - US Dollar

Abcam PLC Key Financial Ratios

Abcam Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abcam PLC's current stock value. Our valuation model uses many indicators to compare Abcam PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abcam PLC competition to find correlations between indicators driving Abcam PLC's intrinsic value. More Info.
Abcam PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  12.46  of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Abcam PLC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Abcam PLC Market Pulse

 Quote23.59
 Change(%)  2.32 
 Change0.56 
 Open24.15
 Low23.53
 High24.52
 Volume0
 ExchangeNASDAQ

Abcam PLC December 2, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Abcam PLC help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Abcam PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Abcam PLC based on widely used predictive technical indicators. In general, we focus on analyzing Abcam Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Abcam PLC's daily price indicators and compare them against related drivers.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Abcam Stock

If you are still planning to invest in Abcam PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abcam PLC's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital